Automata was founded with a clear aim: to unlock human potential with automation.Through our collaboration with some of the world’s leading pathology labs, we’ve developed the most comprehensive lab automation platform on the market. By simplifying environments and empowering people, Automata enables labs to scale with precision and creates new opportunities for scientists to accelerate innovation. https://automata.tech/

Lightship believe clinical research can be built to improve health equity globally. Learning if treatments are safe and effective for the people who need them requires us to offer studies that are more accessible and offer choice. Lightship was founded in 2018 with the inspiration to keep people at the heart of our work and use the latest innovations in digital health, technology, and remote care melded with high quality clinical research to transform clinical trials. The Lightship approach offers clinical trials that are designed from the beginning to make it easier for patients and caregivers to take part. By using inclusive technology, flexible visit types, an amazing experience, and commitment to quality, we can develop programs to better bring new potentially life-saving therapies into the world, together.

One of the world’s leading health and wellness retailers and the largest in Europe, with over 1,300 stores in 16 countries and a strong online offer. PE-backed, by L1 Retail. In addition to providing formal NED governance and scrutiny, I am supporting the H&B Exec team to support their digital and transformation activities on their journey to a leading global wellness destination, adding quality years to life. The H&B team are focused on a hugely ambitious vision to improve the wellness of millions of people around the world. I am providing support to a number of fucntions across the business, in particular Strategy, Transformation, M&A/Investments, ESG, the Group Science and Medical function and the Wellness Futures business line, which incubates and scales new propositions around wellness services and solutions through a combination of venture-building and partnerships.

Joint partner at £500m fund of funds with a focus on providing growth and scaling capital to businesses that drive positive social impact alongside market returns. Flexible geographic mandate. Particular interest in solutions that support population-level health improvements, reducing health inequalities, education and financial inclusion.

Talking with patients is the basis of all healthcare. Ufonia combines AI and clinical evidence to automate routine telephone consultations.Ufonia's technology makes care more convenient, reliable and consistent for patients; increases hospitals’ capacity; and allows clinical professionals to spend more time meeting patients’ needs.

At Thriva, we’re on a mission to help millions of people worldwide become actively invested in their long term health. Through using health insights to help them thrive.

METTLE is the digital toolkit for men's minds. The app that gives men the permission and tools they need to look after their mental health. Currently in seed fundraising round in stealth mode but big news soon...

www.musichealth.ai - Empowering humans to become the superheroes of their brain health using the power of music - initially in dementia care

Recent winners of the London Tech Week pitch contest - Symbiotex are a seaweed based, home compostable rigid and semi-rigid biomaterials company focused on lowering the carbon footprint of the medical devices industry.

The future experience for people with cancer will be fundamentally different to what it is today. There are huge opportunities in medical technology, cancer services innovation, and system change that could significantly improve how people are diagnosed and treated, as well as how cancer is managed as a long-term condition. There are, however, huge challenges ahead, from lack of funding to workforce shortages and inequity of care. Investing money in the right way to deliver the most impact is not only a vital part of Macmillans 100-year history but their future too. The Macmillan Innovation Impact Investment Portfolio was launched at the beginning of 2023 and is a new way for Macmillan to invest in ground-breaking innovations in cancer care. It is a test and, therefore, relatively modest: investing £ 3.5 million over the next two years in the most innovative ideas and pioneering cancer products.

The UN Health Innovation Exchange (HIEx) identifies challenges faced by implementers and connects them with innovations that have high potential for impact. Launched on the sidelines of the World Health Assembly in Geneva in May 2019, the HIEx is a UNAIDS initiative driving global policy change through investment.

Advise Inc bring visibility to healthcare supply chains - they are the go-to platform for price and value chain analysis in the UK/ NHS

Tympa is a team of doctors and technology experts united by a mission to help the world achieve better ear and hearing health. They have set out to create the world’s first all-in-one ear and hearing healthcare assessment platform, designed to deliver and accelerate both diagnosis and treatment within a single 30-minute appointment. I led the Octopus Ventures investment into Tympa in December 2022, one of the largest Series A rounds in Healthtech in Europe in the last 12 months.

Little Journey is a digital eSupport platform designed to psychologically prepare, support and inform children and families before, during and after healthcare interactions - both those occurring as part of a clinical trial and within routine care. www.littlejourney.health. I led the Octopus Ventures lead seed round investment into Little Journey in 2022.

Mango Sciences is a leading emerging market data science company connecting millions of underrepresented patients to precision medicine. The company’s Querent™ platform utilizes industry-leading AI analytics to transform deep clinical data into key insights that drive global health improvements. Mango Sciences is currently partnering with hospitals to understand the health data of individuals in India and other emerging markets to drive advancement in patient care and drug discovery for all populations. https://mangosciences.com/

With over £1.8bn AuM and a team of nearly 100 people investing over £200m a year,, Octopus Ventures are one of the largest VC funds in Europe and one of the most active in Healthtech. Investing from seed stage through to Series C with a vision to improve billions of lives by 2030, I jointly led the healthtech team after the acquisition of TenX Health (the VC I founded in 2018). It's a pretty interesting organisation.

Board Trustee for the RSPH to support them in becoming more commercial and help drive the shift we need in the way the UK public view and manage their own health and wellbeing. The NHS is one of the best health systems in the world but it can't succeed without more innovative approaches to technology and financial incentives, public health plays a critical part in this.

Google Health are doing some incredible things. Before the acquisition of TenX Health by Octopus, I had the privilege to work for a short time with the US leadership team to help shape the go to market strategy in the UK, working with the team to help prioritise which solutions would resonate best in the public healthcare systems of Europe.

Co-Founder and Managing Partner of TenX Health, an independent VC dedicated to high growth healthtech investments across Europe. As a boutique fund, we provided hands-on support to carefully selected startups looking to scale in Europe, the US and India, offering significant go-to-market support, deep tech capability and senior market access. The fund team joined Octopus Ventures at the end of 2020 to rapidly accelerate our ambition to improve over 1 Billion Lives through healthtech.

Working with a high growth technology platform to take the business through private beta through to full public launch. I worked with the founders to help shape their global growth strategy, develop an operating model that will allow them to scale quickly over time and helped them make over 40 well-informed strategic decisions with confidence over a short period of time.

Leading the EY UK Ventures business, investing in high growth healthcare technology businesses (internal and third party) to lead their go to market strategy and achieve differential scale. Managed a portfolio of over 10 businesses from seed stage through to Series A.

UK lead for EYs healthcare managed services business - providing long term solutions to government clients and developing new digital solutions to complement our consulting businessProud to be partner sponsor for HealthEY - EYs internal transformation programme to provide world class support to our 12,000 people in the UK for their physical and mental wellbeing.

UK Healthcare Consulting partner specialising in all aspects of provider performance improvement, health economy strategy and NHS change. EY Global leader for healthcare supply chain, working with health systems around the world to transform their procurement and supply chain capabilities and drive greater value from the supply base. At 35, priveleged to be one of the youngest people to become a full equity partner in the UK firm.

Specialising in NHS commercial strategy, commisioning reform, clinical reconfiguration & acute provider cost reduction

Co-founded a business established to disrupt the temporary staffing sector in healthcare (https://ryaltoapp.com/) - supporting healthcare porfessionals to manage their working lives in a more flexible way and presenting the opportunity to save the NHS over £1bn in unnecessary agency fees.

Advisory board member to Buddy, an innovative social enterprise providing a mental health diary tool to support people with conditions such as depression

Grew a consulting business with two ex colleagues from KPMG Consulting (Rob Garner & Martin Wilson) to over 60 FTEs and £12m in annual revenues, within the Tribal Group of companies, one of the largest publicly listed organisations specialising in the UK public sector. Avail was ultimately acquired by Capita.

Consulting assistant in packaging design and logistics.